Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | DPP4 | P27487 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8329623 | 0.97 | LMNA (0.42) | LMNASMN1; SMN2ALDH1A1TSHRHSD17B10 | |
| SCHEMBL6577653 | 0.90 | THRB (0.35) | LMNASMN1; SMN2ALDH1A1TSHRTHRB | |
| SCHEMBL6925076 | 0.90 | LMNA (0.46) | LMNASMN1; SMN2ALDH1A1TSHRHSD17B10 | |
| SCHEMBL9702342 | 0.90 | LMNA (0.46) | LMNASMN1; SMN2ALDH1A1TSHRHSD17B10 | |
| SCHEMBL2451368 | 0.88 | LMNA (0.52) | LMNASMN1; SMN2ALDH1A1TSHRHSD17B10 | |
| SCHEMBL14830612 | 0.87 | GSR (0.33) | LMNAALDH1A1TSHR | |
| SCHEMBL4850725 | 0.87 | LMNA (0.36) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL8997997 | 0.87 | LMNA (0.46) | LMNASMN1; SMN2ALDH1A1TSHRHSD17B10 | |
| SCHEMBL8072510 | 0.85 | LMNA (0.56) | LMNASMN1; SMN2ALDH1A1TSHRHSD17B10 | |
| SCHEMBL6903763 | 0.85 | LMNA (0.56) | LMNASMN1; SMN2ALDH1A1TSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117844431-A | Thermoplastic polyurethane adhesive, preparation method and application thereof | 万华化学集团股份有限公司 | 2024-04-09 | — | — | CN | claimed |
| CN-114316197-B | Thermoplastic polyurethane adhesive with low polarity and high heat resistance and application thereof | 万华化学集团股份有限公司 | 2023-07-14 | — | — | CN | claimed |
| CN-114316197-A | Low-polarity high-heat-resistance thermoplastic polyurethane adhesive and application thereof | 万华化学集团股份有限公司 | 2022-04-12 | — | — | CN | claimed |
| CN-117844431-A | Thermoplastic polyurethane adhesive, preparation method and application thereof | 万华化学集团股份有限公司 | 2024-04-09 | — | — | CN | disclosed |
| CN-114316197-B | Thermoplastic polyurethane adhesive with low polarity and high heat resistance and application thereof | 万华化学集团股份有限公司 | 2023-07-14 | — | — | CN | disclosed |
| US-11446398-B2 | Regulated biocircuit systems | OBSIDIAN THERAPEUTICS, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| CN-114316197-A | Low-polarity high-heat-resistance thermoplastic polyurethane adhesive and application thereof | 万华化学集团股份有限公司 | 2022-04-12 | — | — | CN | disclosed |
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| US-20190192691-A1 | REGULATED BIOCIRCUIT SYSTEMS | OBSIDIAN THERAPEUTICS, INC. | 2019-06-27 | — | — | US | disclosed |